Search results

Articles (6)

Journals (0)

1-6 of 6 results for elderly PAH

Sort by:

Relevance

Select all

Sort by:

Relevance

Free accessResearch articleFirst published July, 2020

Characteristics of Japanese elderly patients with pulmonary arterial hypertension

Yukiko Takahashi, Keiko Yamamoto, Nobuhiro Tanabe [...]

Pulmonary Circulation

Free accessResearch articleFirst published March, 2014

Effects of Dose and Age on Adverse Events Associated with Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Erika Berman-Rosenzweig, Carl Arneson, James R. Klinger

Pulmonary Circulation

Free accessResearch articleFirst published March, 2016

Effects of Age and Sex on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521)

Reiner Frey, Soundos Saleh, Corina Becker [...]

Pulmonary Circulation

Open accessReview articleFirst published 2019

Practical management of riociguat in patients with pulmonary arterial hypertension

Michael Halank, Kristin Tausche, Ekkehard Grünig [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2026

Evaluating the Role of Roadside Green Belts in Mitigating Particulate Matter-Bound Polycyclic Aromatic Hydrocarbon Pollution

Hossein Rezai, Abulfazl Rahmani-Sani, Hadi Lotfi [...]

Environmental Health Insights

Open accessResearch articleFirst published January, 2018

Selective improvement of pulmonary arterial hypertension with a dual ET A /ET B receptors antagonist in the apolipoprotein E −/− model of PAH and atherosclerosis

Lewis Renshall, Nadine Arnold, Laura West [...]

Pulmonary Circulation

Search results

Articles (6)

Journals (0)

1-6 of 6 results for elderly PAH

Sort by:

Relevance

Select all

Sort by:

Relevance

Free accessResearch articleFirst published July, 2020

Characteristics of Japanese elderly patients with pulmonary arterial hypertension

Yukiko Takahashi, Keiko Yamamoto, Nobuhiro Tanabe [...]

Pulmonary Circulation

Free accessResearch articleFirst published March, 2014

Effects of Dose and Age on Adverse Events Associated with Tadalafil in the Treatment of Pulmonary Arterial Hypertension

Erika Berman-Rosenzweig, Carl Arneson, James R. Klinger

Pulmonary Circulation

Free accessResearch articleFirst published March, 2016

Effects of Age and Sex on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521)

Reiner Frey, Soundos Saleh, Corina Becker [...]

Pulmonary Circulation

Open accessReview articleFirst published 2019

Practical management of riociguat in patients with pulmonary arterial hypertension

Michael Halank, Kristin Tausche, Ekkehard Grünig [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2026

Evaluating the Role of Roadside Green Belts in Mitigating Particulate Matter-Bound Polycyclic Aromatic Hydrocarbon Pollution

Hossein Rezai, Abulfazl Rahmani-Sani, Hadi Lotfi [...]

Environmental Health Insights

Open accessResearch articleFirst published January, 2018

Selective improvement of pulmonary arterial hypertension with a dual ET A /ET B receptors antagonist in the apolipoprotein E −/− model of PAH and atherosclerosis

Lewis Renshall, Nadine Arnold, Laura West [...]

Pulmonary Circulation